After losing Roche as a partner, Blueprint Medicines has sold US commercial rights to RET inhibitor Gavreto to Rigel Pharma in a deal worth up to $117.5 million.

Starc writes to DC confirming exit from IPL 2025 season by Vijay Tagore • Last updated on Sun, Jul 6, 2025, 10:43 AM ...

Arsenal winger signing relies on Martinelli exit David Ornstein has hinted that Arsenal would have to sell a left winger, such as Gabriel Martinelli, if they were to sign Rodrygo or Anthony Gordon.